Transfecting of HEK-293T Cells Using Calcium Phosphate
2:19
Harvesting Virus
2:50
Concentration of Viral Particles by Ultracentrifugation
5:11
Esimating of Viral Titers Using p24-enzyme-linked Immunosorbent Assay
7:31
Counting GFP-positive Cells
8:25
Results: Production and Validation of the Knockout-efficiency of Integrase-deficient Lentiviral-CRSPER/Cas9 Vector
9:57
Conclusion
Transcript
The overall goal of this protocol is to describe the production and potential applications of optimized integrase-deficient lentiviral vectors capable of delivering CRISPR/Cas9 transgenes to cells in vivo and in vitro for rapid and efficient gene
Sign in or start your free trial to access this content
Describimos la estrategia de producción de vectores lentivirales integrasa deficientes (IDLVs) como vehículos para la entrega de CRISPR/Cas9 a las células. Con una capacidad para mediar la edición rápido y robusto gene en células, IDLVs actualmente un seguro y plataforma igualmente eficaz vector de genes en comparación con vectores competentes integrasa.